Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Boonstra

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Annals of Hepatology|November 19, 2023
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and EuropeansSiyu Fu, Dhamina Karim, Jhon Prieto, et al.
Scientific Reports|August 17, 2017
Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized miceMartijn D B van de Garde, Suzan D Pas, Gertine W van Oord, et al.
Journal of Hepatology|November 3, 2024
Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis BZgjim Osmani, Willem Pieter Brouwer, Dwin G B Grashof, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis BEric T T L Tjwa, Roeland Zoutendijk, Gertine W van Oord, et al.
Gastroenterology|November 6, 2017
Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting AntiviralsJose D Debes, Marjolein van Tilborg, Zwier M A Groothuismink, et al.
Journal of Viral Hepatitis|September 2, 2020
Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up studyBoris J B Beudeker, Zwier M A Groothuismink, Robert A de Man, et al.
Viruses|November 27, 2025
HBV Infection Drives PSMB5-Dependent Proteasomal Activation in Humanized Mice and HBV-Associated HCCAyse Tarbin Jannuzzi, Gulce Sari, Sema Arslan-Eseryel, et al.
Journal of Hepatology|February 26, 2022
Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infectionNoe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal, et al.
Molecular Immunology|July 21, 2012
Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patientsArjan Boltjes, Marjoleine L Op den Brouw, Paula J Biesta, et al.
Scientific Reports|November 18, 2018
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapyN Chantal Peltenburg, Johannes C Schoeman, Jun Hou, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Annals of Hepatology|November 19, 2023
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and EuropeansSiyu Fu, Dhamina Karim, Jhon Prieto, et al.
Scientific Reports|August 17, 2017
Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized miceMartijn D B van de Garde, Suzan D Pas, Gertine W van Oord, et al.
Journal of Hepatology|November 3, 2024
Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis BZgjim Osmani, Willem Pieter Brouwer, Dwin G B Grashof, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis BEric T T L Tjwa, Roeland Zoutendijk, Gertine W van Oord, et al.
Gastroenterology|November 6, 2017
Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting AntiviralsJose D Debes, Marjolein van Tilborg, Zwier M A Groothuismink, et al.
Journal of Viral Hepatitis|September 2, 2020
Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up studyBoris J B Beudeker, Zwier M A Groothuismink, Robert A de Man, et al.
Viruses|November 27, 2025
HBV Infection Drives PSMB5-Dependent Proteasomal Activation in Humanized Mice and HBV-Associated HCCAyse Tarbin Jannuzzi, Gulce Sari, Sema Arslan-Eseryel, et al.
Journal of Hepatology|February 26, 2022
Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infectionNoe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal, et al.
Molecular Immunology|July 21, 2012
Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patientsArjan Boltjes, Marjoleine L Op den Brouw, Paula J Biesta, et al.
Scientific Reports|November 18, 2018
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapyN Chantal Peltenburg, Johannes C Schoeman, Jun Hou, et al.
Pageof 11